Product Code: ETC13322021 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Hospital Acquired Urinary Tract Infection Market was valued at USD 2.7 Billion in 2024 and is expected to reach USD 3.95 Billion by 2031, growing at a compound annual growth rate of 5.10% during the forecast period (2025-2031).
The Global Hospital Acquired Urinary Tract Infection Market is experiencing steady growth due to the increasing prevalence of healthcare-associated infections. Factors such as the rising geriatric population, the growing number of catheter-associated urinary tract infections, and the spread of antibiotic-resistant bacteria are driving market expansion. Key players in the market are focusing on developing advanced diagnostic tools, effective treatment options, and preventative strategies to reduce the incidence of hospital-acquired UTIs. Additionally, healthcare facilities are implementing stringent infection control measures and protocols to minimize the risk of UTIs. The market is characterized by collaborations, partnerships, and product launches aimed at addressing the unmet needs in this sector. Geographically, North America dominates the market due to the high healthcare expenditure and advanced healthcare infrastructure.
The Global Hospital Acquired Urinary Tract Infection (HAUTI) market is witnessing a growing demand for advanced diagnostic tools and treatments due to the increasing prevalence of healthcare-associated infections. Key trends include a shift towards preventive measures such as catheter-associated UTI reduction protocols and the adoption of antimicrobial stewardship programs in healthcare facilities. Opportunities in the market lie in the development of innovative technologies for rapid and accurate diagnosis, as well as the introduction of novel treatment options to combat HAUTIs effectively. With a focus on infection control practices and increased awareness among healthcare professionals, the HAUTI market is poised for significant growth in the coming years, presenting lucrative prospects for companies operating in this sector.
The Global Hospital Acquired Urinary Tract Infection Market faces several challenges, including the rising prevalence of antibiotic-resistant strains of bacteria, inadequate infection prevention measures in healthcare facilities, and the lack of awareness among healthcare professionals and patients regarding the importance of preventing urinary tract infections. Additionally, limited access to proper diagnostic tools and high treatment costs further hinder the market growth. The increasing burden of regulatory requirements and the need for stringent infection control practices also pose challenges for market players. Overall, addressing these challenges requires a multi-faceted approach involving improved infection control strategies, increased awareness campaigns, and the development of innovative solutions to combat antibiotic resistance.
The Global Hospital Acquired Urinary Tract Infection (HAUTI) market is primarily driven by the increasing prevalence of HAUTIs due to the rising number of hospital admissions and surgeries globally. Factors such as the growing aging population, higher incidence of chronic diseases, and the widespread use of urinary catheters in healthcare settings contribute to the high incidence of HAUTIs. Additionally, the increasing awareness about HAUTIs among healthcare providers and patients, along with the implementation of stringent infection control protocols in hospitals, are driving the demand for diagnostic tests and treatment options for HAUTIs. Furthermore, the rising focus on healthcare-associated infections and the development of novel therapies and preventive measures are expected to drive market growth in the coming years.
Government policies related to the Global Hospital Acquired Urinary Tract Infection (HAUTI) Market often focus on infection control measures, antimicrobial stewardship programs, and surveillance systems to prevent and manage these healthcare-associated infections. Regulatory bodies like the Centers for Disease Control and Prevention (CDC) in the United States provide guidelines and recommendations for healthcare facilities to reduce the incidence of HAUTIs through proper catheter use, hand hygiene, and environmental cleaning practices. Additionally, reimbursement policies from government healthcare programs may incentivize hospitals to implement strategies that lower infection rates, such as reducing catheter-associated UTIs through the use of appropriate catheter insertion and maintenance techniques. Overall, government policies play a crucial role in shaping the landscape of the HAUTI market by emphasizing prevention and containment strategies to improve patient outcomes and healthcare quality.
The Global Hospital Acquired Urinary Tract Infection Market is expected to witness steady growth in the coming years due to the increasing prevalence of healthcare-associated infections and the rising geriatric population. Factors such as the growing awareness about the importance of infection control measures in healthcare settings, advancements in diagnostic techniques, and the development of novel treatment options are likely to drive market expansion. Additionally, the implementation of stringent regulations and guidelines by healthcare authorities to prevent hospital-acquired infections is anticipated to further propel market growth. However, factors such as the high cost of treatment and the emergence of antibiotic resistance pose challenges to market growth. Overall, the market is projected to experience moderate but steady growth in the foreseeable future.
In the global hospital-acquired urinary tract infection market, different regions exhibit varying trends. Asia Pacific is expected to witness significant growth due to increasing healthcare infrastructure development and rising awareness about infection control. North America leads the market with advanced healthcare facilities and stringent regulations for infection prevention. Europe follows closely with a growing geriatric population susceptible to urinary tract infections. The Middle East and Africa region show potential for market growth, driven by improving healthcare systems and rising investments in hospital infrastructure. Latin America is also witnessing steady growth due to increasing healthcare expenditure and a rising number of hospital-acquired infections, creating opportunities for market expansion in the region.
Global Hospital Acquired Urinary Tract Infection Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Hospital Acquired Urinary Tract Infection Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Hospital Acquired Urinary Tract Infection Market Revenues & Volume, 2021 & 2031F |
3.3 Global Hospital Acquired Urinary Tract Infection Market - Industry Life Cycle |
3.4 Global Hospital Acquired Urinary Tract Infection Market - Porter's Five Forces |
3.5 Global Hospital Acquired Urinary Tract Infection Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Hospital Acquired Urinary Tract Infection Market Revenues & Volume Share, By Infection Type, 2021 & 2031F |
3.7 Global Hospital Acquired Urinary Tract Infection Market Revenues & Volume Share, By Diagnostic Method, 2021 & 2031F |
3.8 Global Hospital Acquired Urinary Tract Infection Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Global Hospital Acquired Urinary Tract Infection Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Global Hospital Acquired Urinary Tract Infection Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Hospital Acquired Urinary Tract Infection Market Trends |
6 Global Hospital Acquired Urinary Tract Infection Market, 2021 - 2031 |
6.1 Global Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Catheter-associated UTI, 2021 - 2031 |
6.1.3 Global Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Drug-resistant UTI, 2021 - 2031 |
6.1.4 Global Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Recurrent UTI, 2021 - 2031 |
6.1.5 Global Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Asymptomatic Bacteriuria, 2021 - 2031 |
6.2 Global Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Diagnostic Method, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Urine Culture, 2021 - 2031 |
6.2.3 Global Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By PCR-based Testing, 2021 - 2031 |
6.2.4 Global Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Microscopy, 2021 - 2031 |
6.2.5 Global Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Rapid Dipstick Tests, 2021 - 2031 |
6.3 Global Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Long-term Care Patients, 2021 - 2031 |
6.3.3 Global Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Hospitalized Patients, 2021 - 2031 |
6.3.4 Global Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Elderly Patients, 2021 - 2031 |
6.3.5 Global Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Outpatient Clinics, 2021 - 2031 |
6.4 Global Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Infection Monitoring, 2021 - 2031 |
6.4.3 Global Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Antibiotic Resistance Detection, 2021 - 2031 |
6.4.4 Global Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Chronic Infection Management, 2021 - 2031 |
6.4.5 Global Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Early Detection, 2021 - 2031 |
7 North America Hospital Acquired Urinary Tract Infection Market, Overview & Analysis |
7.1 North America Hospital Acquired Urinary Tract Infection Market Revenues & Volume, 2021 - 2031 |
7.2 North America Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
7.4 North America Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Diagnostic Method, 2021 - 2031 |
7.5 North America Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 North America Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Application, 2021 - 2031 |
8 Latin America (LATAM) Hospital Acquired Urinary Tract Infection Market, Overview & Analysis |
8.1 Latin America (LATAM) Hospital Acquired Urinary Tract Infection Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
8.4 Latin America (LATAM) Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Diagnostic Method, 2021 - 2031 |
8.5 Latin America (LATAM) Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By End User, 2021 - 2031 |
8.6 Latin America (LATAM) Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Application, 2021 - 2031 |
9 Asia Hospital Acquired Urinary Tract Infection Market, Overview & Analysis |
9.1 Asia Hospital Acquired Urinary Tract Infection Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
9.4 Asia Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Diagnostic Method, 2021 - 2031 |
9.5 Asia Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By End User, 2021 - 2031 |
9.6 Asia Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Application, 2021 - 2031 |
10 Africa Hospital Acquired Urinary Tract Infection Market, Overview & Analysis |
10.1 Africa Hospital Acquired Urinary Tract Infection Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
10.4 Africa Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Diagnostic Method, 2021 - 2031 |
10.5 Africa Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By End User, 2021 - 2031 |
10.6 Africa Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Application, 2021 - 2031 |
11 Europe Hospital Acquired Urinary Tract Infection Market, Overview & Analysis |
11.1 Europe Hospital Acquired Urinary Tract Infection Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
11.4 Europe Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Diagnostic Method, 2021 - 2031 |
11.5 Europe Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By End User, 2021 - 2031 |
11.6 Europe Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Application, 2021 - 2031 |
12 Middle East Hospital Acquired Urinary Tract Infection Market, Overview & Analysis |
12.1 Middle East Hospital Acquired Urinary Tract Infection Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Infection Type, 2021 - 2031 |
12.4 Middle East Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Diagnostic Method, 2021 - 2031 |
12.5 Middle East Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By End User, 2021 - 2031 |
12.6 Middle East Hospital Acquired Urinary Tract Infection Market, Revenues & Volume, By Application, 2021 - 2031 |
13 Global Hospital Acquired Urinary Tract Infection Market Key Performance Indicators |
14 Global Hospital Acquired Urinary Tract Infection Market - Export/Import By Countries Assessment |
15 Global Hospital Acquired Urinary Tract Infection Market - Opportunity Assessment |
15.1 Global Hospital Acquired Urinary Tract Infection Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Hospital Acquired Urinary Tract Infection Market Opportunity Assessment, By Infection Type, 2021 & 2031F |
15.3 Global Hospital Acquired Urinary Tract Infection Market Opportunity Assessment, By Diagnostic Method, 2021 & 2031F |
15.4 Global Hospital Acquired Urinary Tract Infection Market Opportunity Assessment, By End User, 2021 & 2031F |
15.5 Global Hospital Acquired Urinary Tract Infection Market Opportunity Assessment, By Application, 2021 & 2031F |
16 Global Hospital Acquired Urinary Tract Infection Market - Competitive Landscape |
16.1 Global Hospital Acquired Urinary Tract Infection Market Revenue Share, By Companies, 2024 |
16.2 Global Hospital Acquired Urinary Tract Infection Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |